Featured News Story
12 March 2019

Daratumumab combination treatment approved for NHS use in England and Wales through the Cancer Drugs Fund

Myeloma patients at first relapse in England and Wales will now be able to access the new treatment of daratumumab (Darzalex®), bortezomib (Velcade®) and dexamethasone on the NHS after it was approved for use through the Cancer Drugs Fund (CDF).

Featured News Story
26 February 2019

NHS England’s 10 year plan: new ways to provide care ‘out-of-hospital’

The Myeloma UK Patient Advocacy team looks at ‘out-of-hospital’ care and its place at the heart of what NHS England's 10 year plan.

Featured News Story
31 January 2019

NHS England’s 10 year plan: detecting and diagnosing cancer more quickly

The Myeloma UK Patient Advocacy Team takes a look at the NHS England 10 year plan, and the implications it will have for myeloma patients.

Featured News Story
04 September 2018

Myeloma UK joins campaign putting the spotlight on blood cancers

Featured News Story
12 July 2018

NICE issues draft “no” on daratumumab combination

News Story
23 March 2018

Myeloma UK attends several conferences about blood cancers

News Story
20 March 2018

Myeloma UK signs letter to MPs about future of cancer research post-Brexit

News Story
06 December 2017

Myeloma UK Patient Information is awarded quality mark

News Story
28 November 2017

Myeloma Early Diagnosis Working Group have last meeting of 2017

Older posts